Clinical Trial

Adjuvant Clopidogrel in Staphylococcus Aureus Bacteremia

Study acronym: CLOPI-SNAP
Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The CLOPI-SNAP study is a randomized, multicenter, open-label clinical trial embedded within the SNAP (NCT 05137119) research platform. It constitutes a sub-study added to the core protocol for patients suffering Staphylococcus aureus bacteremia (SAB).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-27.
Trial Details
NCT Number NCT07384702
Lead Sponsor Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Collaborators: University of Melbourne
Conditions Bacteremia Due to Staphylococcus Aureus
Enrollment 230 participants
Start Date 2026-06
Primary Completion 2030-06 (estimated)
Study Completion 2030-06 (estimated)
Updated on ClinicalTrials.gov 2026-02-05